Free Trial

Canopy Growth (CGC) to Release Earnings on Friday

Canopy Growth logo with Medical background
Remove Ads

Canopy Growth (NASDAQ:CGC - Get Free Report) will likely be releasing its Q3 2025 earnings data before the market opens on Friday, February 7th. Analysts expect Canopy Growth to post earnings of ($0.38) per share and revenue of $69.45 million for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.

Canopy Growth Stock Down 27.3 %

NASDAQ CGC traded down $0.76 during trading hours on Friday, reaching $2.02. 22,890,203 shares of the company's stock traded hands, compared to its average volume of 7,716,115. Canopy Growth has a 52-week low of $1.85 and a 52-week high of $14.92. The firm has a market cap of $263.47 million, a PE ratio of -0.41 and a beta of 0.86. The firm has a 50-day simple moving average of $2.70 and a 200 day simple moving average of $4.26. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.39 and a quick ratio of 1.07.

Wall Street Analyst Weigh In

Separately, Atb Cap Markets lowered shares of Canopy Growth from a "hold" rating to a "strong sell" rating in a research note on Monday, December 16th.

View Our Latest Research Report on CGC

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Recommended Stories

Earnings History for Canopy Growth (NASDAQ:CGC)

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads